Company: TGNT
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001477932-25-005790
Chunk: 30

Company: Totaligent, Inc.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 30
---
 shares         Series D preferred stock, $0.01 par value; authorized –1,000,000 shares; issued and outstanding – 576,562 and 713,750 shares at June 30, 2025 and December 31, 2024, respectively  5,766   7,138 Common stock, $0.001 par value; authorized – 500,000,000 shares; 211,101,313 shares issued and 211,101,313 and 172,913,813 outstanding as of June 30, 2025 and December 31, 2024, respectively  211,101   211,101 Shares to be issued  5,476   5,476 Additional paid-in capital  990   818,577 Accumulated deficit  (2,180,835)  (1,807,363)Treasury stock, 0 and 38,187,500 outstanding  -   (972,181)Total stockholders’ deficit  (1,957,502)  (1,737,252)Total liabilities and stockholders’ deficit $245,070  $222,925 

The accompanying notes are an integral part of these unaudited consolidated financial statements 

 F-1Table of Contents

TOTALIGENT, INC. AND SUBSIDIARY 

CONSOLIDATED STATEMENTS OF OPERATIONS 

UNAUDITED 

   For the Three Months Ended    For the Six Months Ended    June 30,   June 30,     2025    2024    2025    2024               Revenue $-  $73,610  $-  $414,539                  Cost of revenue  -   37,532   -   334,610                  Gross profit  -   36,078   -   79,929                  Operating expenses:                Consulting expenses  -   155   -   35,405 Personnel expenses  30,000   94,500   30,000   194,000 General and administrative  74,505   47,283   152,528   123,832 Total operating expenses  104,